Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and ...
Sanofi India share price gained up to 6% in morning trades on Friday post Q4 results announced by the company after the ...
With a market valuation of Rs 11,574.76 Cr, Sanofi Indias shares ended Fridays trading session on the BSE 0.58% higher at Rs ...
Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...
DIsney says it has sold out all commercial inventory for Sunday's Oscars, and notes packages include TV, streaming, social ...
Home First Finance Company India Ltd, Sanofi India Ltd, Valor Estate Ltd and Jindal Saw Ltd are among the other gainers in the BSE's 'A' group today, 28 February 2025.
Prestige Estates Projects Ltd recorded volume of 3.67 lakh shares by 10:47 IST on BSE, a 17.27 times surge over two-week average daily volume of 21272 shares ...
2d
Hosted on MSNNovavax Lands Wall Street 'Buy' Rating After Q4 Results, Retail Bulls Eye More Upside On Sanofi PartnershipNovavax Inc. (NVAX) shares climbed over 1% in after-hours trading Thursday as the vaccine maker's revenue outlook and ...
An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the ...
The company's molecular research and drug-development platform taps what it calls nature's wisdom to drive the discovery of ...
Transitioned lead commercial responsibility of Nuvaxovid COVID-19 vaccine to Sanofi beginning with the 2025-2026 season Achieved total revenue of $88 million in ...
Novavax (NVAX) reported a large fourth quarter sales decline Thursday — and said it no longer wants to be known simply as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results